01—Abstract
Summary
Summary of the 8-K filed May 8, 2025. Cited figures are marked; the original filing is the authoritative source.
West Pharmaceutical Services, Inc. (WST) filed this Current Report on Form 8-K to disclose the results of its 2025 Annual Meeting of Shareholders, which was held virtually on May 6, 2025.
Shareholders representing 65,014,244 common shares, or 89.93%a of the 72,292,731 shares outstanding as of the February 28, 2025 record date, were present or represented by proxy. Shareholders voted on five proposals described in the proxy statement dated March 21, 2025. All twelve director nominees were elected to serve until the 2026 Annual Meeting.
Shareholders also approved, on an advisory basis, the compensation of the named executive officers; approved an amendment and restatement of the Articles of Incorporation to add a shareholder right to call a special meeting; approved an amendment and restatement of the 2016 Omnibus Incentive Compensation Plan; and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2025. Each of these proposals received more For votes than Against votes. The filing also includes, as Exhibit 5.7, the Amended and Restated Articles of Incorporation dated May 6, 2025, which reflect the shareholder special meeting right approved at the meeting.
02—Key points
Key Highlights
- Annual Meeting held virtually on May 6, 2025, with 65,014,244 shares (89.93% of 72,292,731 outstanding as of the February 28, 2025 record date) present or represented by proxy.
- All 12 director nominees were elected to serve until the 2026 Annual Meeting; Eric M. Green (5,326,139 against) and Deborah L. V. Keller (7,367,368 against) received the most Against votes among nominees.
- Shareholders approved, on an advisory basis, named executive officer compensation with 59,222,338 For votes against 3,516,476 Against votes.
- Shareholders approved an amendment and restatement of the Articles of Incorporation adding a right for shareholders to call a special meeting, with 62,707,017 For votes against 88,400 Against votes.
- Shareholders approved the amendment and restatement of the 2016 Omnibus Incentive Compensation Plan, with 60,862,053 For votes against 1,883,395 Against votes.
- Shareholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2025, with 60,537,221 For votes against 4,373,036 Against votes.
- Exhibit 5.7 contains the Amended and Restated Articles of Incorporation dated May 6, 2025.
03—Questions
Frequently Asked Questions
When and how was the 2025 Annual Meeting of Shareholders held?
The meeting was held virtually on May 6, 2025. Shareholders representing 65,014,244 common shares, or 89.93% of shares outstanding as of the February 28, 2025 record date, were present virtually or by proxy.
Were all director nominees elected?
Yes. All twelve nominees were elected to serve on the Board until the 2026 Annual Meeting of Shareholders. Each nominee received substantially more For votes than Against votes, though Deborah L. V. Keller received 7,367,368 Against votes and Eric M. Green received 5,326,139 Against votes.
What change to shareholder rights was approved?
Shareholders approved an amendment and restatement of the Articles of Incorporation adding a right for shareholders to call a special meeting, with 62,707,017 For votes and 88,400 Against votes. The amended articles are filed as Exhibit 5.7 and are dated May 6, 2025.
Did shareholders approve the executive compensation and the equity plan?
Yes. The advisory vote on named executive officer compensation passed with 59,222,338 For and 3,516,476 Against votes. The amendment and restatement of the 2016 Omnibus Incentive Compensation Plan passed with 60,862,053 For and 1,883,395 Against votes.
Who was ratified as the independent auditor for 2025?
Shareholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the 2025 fiscal year, with 60,537,221 For votes, 4,373,036 Against votes, and 103,987 Abstain votes.
04—Continue